MLX 380 - European Commission’s proposal for a Clinical Trials Regulation

The Medicines and Healthcare products Agency (MHRA) is consulting on the European Commission’s proposal for a Clinical Trials Regulation. The Government is committed to ensuring that the European Union (EU) regulatory framework for clinical trials does not create unnecessary burdens on researchers and makes the EU an attractive place to conduct clinical trials. We are interested to hear the views from interested parties on the Commission’s proposal.